DK1075473T3 - Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer - Google Patents

Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer

Info

Publication number
DK1075473T3
DK1075473T3 DK99917668T DK99917668T DK1075473T3 DK 1075473 T3 DK1075473 T3 DK 1075473T3 DK 99917668 T DK99917668 T DK 99917668T DK 99917668 T DK99917668 T DK 99917668T DK 1075473 T3 DK1075473 T3 DK 1075473T3
Authority
DK
Denmark
Prior art keywords
disubstituted
preparation
oxocyclic ureas
oxocyclic
ureas
Prior art date
Application number
DK99917668T
Other languages
Danish (da)
English (en)
Inventor
Patricia Ann Matson
Michael Selden Godlewski
Original Assignee
Procter & Gamble
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble, Lonza Ag filed Critical Procter & Gamble
Application granted granted Critical
Publication of DK1075473T3 publication Critical patent/DK1075473T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK99917668T 1998-04-29 1999-04-27 Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer DK1075473T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8349398P 1998-04-29 1998-04-29
PCT/US1999/009092 WO1999055700A1 (en) 1998-04-29 1999-04-27 Process for making 1,3-disubstituted-4-oxocyclic ureas

Publications (1)

Publication Number Publication Date
DK1075473T3 true DK1075473T3 (da) 2007-11-05

Family

ID=22178700

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99917668T DK1075473T3 (da) 1998-04-29 1999-04-27 Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer

Country Status (28)

Country Link
US (1) US6414151B1 (ja)
EP (1) EP1075473B1 (ja)
JP (1) JP4549531B2 (ja)
KR (1) KR100400050B1 (ja)
CN (1) CN1298403A (ja)
AR (1) AR015044A1 (ja)
AT (1) ATE366251T1 (ja)
AU (1) AU751681B2 (ja)
BR (1) BR9910074A (ja)
CA (1) CA2330686C (ja)
CO (1) CO5070625A1 (ja)
CZ (1) CZ299163B6 (ja)
DE (1) DE69936449T2 (ja)
DK (1) DK1075473T3 (ja)
ES (1) ES2288020T3 (ja)
HU (1) HUP0102666A3 (ja)
ID (1) ID27452A (ja)
IL (1) IL138404A (ja)
MY (1) MY133753A (ja)
NO (1) NO20005424L (ja)
PE (1) PE20000925A1 (ja)
PL (1) PL197776B1 (ja)
RU (1) RU2194706C2 (ja)
SG (1) SG120901A1 (ja)
SK (1) SK15842000A3 (ja)
TR (1) TR200003137T2 (ja)
WO (1) WO1999055700A1 (ja)
ZA (1) ZA200004712B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1075474B1 (en) * 1998-04-29 2004-09-08 The Procter & Gamble Company Process for making 1,3-disubstituted-4-oxocyclic ureas
CN100443473C (zh) * 2005-04-30 2008-12-17 中国药科大学 1-氨基-3-(氮杂环基烷基)-2,4-咪唑二酮的合成方法
US20120178762A1 (en) 2006-12-15 2012-07-12 Warner Chilcott Company, Llc Compositions of azimilide dihydrochloride
TW200840578A (en) * 2006-12-15 2008-10-16 Procter & Gamble Compositions of azimilide dihydrochloride
CN101735202B (zh) * 2009-12-17 2012-05-30 天津药物研究院 盐酸阿齐利特的晶型ⅰ及其制备方法和用途
CN101735205B (zh) * 2009-12-17 2013-05-15 天津药物研究院 盐酸阿齐利特的晶型ⅴ及其制备方法和用途
CN101735203B (zh) * 2009-12-17 2012-05-23 天津药物研究院 盐酸阿齐利特的晶型ⅱ及其制备方法和用途
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919231A (en) 1974-06-17 1975-11-11 Morton Norwich Products Inc Series of 5-aryl-2-furamidines
US3906010A (en) 1974-06-17 1975-09-16 Morton Norwich Products Inc Series of 5-aryl-2-furamidines
US3946049A (en) 1975-04-03 1976-03-23 Morton-Norwich Products, Inc. 5-phenyl-2-furamidoximes
US4001222A (en) 1975-10-14 1977-01-04 Morton-Norwich Products, Inc. 3-(Aminoacyl)-1-{[5-(substituted phenyl)furfurylidene]amino}hydantoins and process for their preparation thereof
JPS5726653A (en) 1980-05-09 1982-02-12 Ciba Geigy Ag Substituted phenyl ether
IL82856A0 (en) 1986-06-26 1987-12-20 Norwich Eaton Pharma Pharmaceutical compositions containing 2-(5-phenyl-2-furanyl)imidazoles and certain such novel compounds
US4882354A (en) 1987-12-16 1989-11-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
US5019651A (en) 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
JP3031973B2 (ja) * 1990-08-16 2000-04-10 富士レビオ株式会社 フェニトイン誘導体
RU2221788C2 (ru) * 1991-08-14 2004-01-20 Проктер энд Гэмбл Фармасьютикалз Оксоциклические соединения мочевины, фармацевтическая композиция, способ лечения
AU665367B2 (en) 1991-08-14 1996-01-04 Procter & Gamble Pharmaceuticals, Inc. Cyclic urethanes useful as antiarrhythmic and antifibrillatory agents
EP1075474B1 (en) * 1998-04-29 2004-09-08 The Procter & Gamble Company Process for making 1,3-disubstituted-4-oxocyclic ureas

Also Published As

Publication number Publication date
AR015044A1 (es) 2001-04-11
KR100400050B1 (ko) 2003-09-29
JP4549531B2 (ja) 2010-09-22
US6414151B1 (en) 2002-07-02
CA2330686A1 (en) 1999-11-04
PL197776B1 (pl) 2008-04-30
CN1298403A (zh) 2001-06-06
CZ299163B6 (cs) 2008-05-07
PL343734A1 (en) 2001-09-10
WO1999055700A1 (en) 1999-11-04
SG120901A1 (en) 2006-04-26
HUP0102666A3 (en) 2002-05-28
ID27452A (id) 2001-04-12
IL138404A (en) 2004-07-25
RU2194706C2 (ru) 2002-12-20
DE69936449D1 (de) 2007-08-16
PE20000925A1 (es) 2000-11-17
CZ20003951A3 (cs) 2001-08-15
CO5070625A1 (es) 2001-08-28
EP1075473A1 (en) 2001-02-14
JP2002513021A (ja) 2002-05-08
IL138404A0 (en) 2001-10-31
SK15842000A3 (sk) 2001-06-11
EP1075473B1 (en) 2007-07-04
NO20005424D0 (no) 2000-10-27
TR200003137T2 (tr) 2001-02-21
CA2330686C (en) 2006-09-26
KR20010043052A (ko) 2001-05-25
BR9910074A (pt) 2000-12-26
ES2288020T3 (es) 2007-12-16
AU751681B2 (en) 2002-08-22
AU3573599A (en) 1999-11-16
MY133753A (en) 2007-11-30
ZA200004712B (en) 2003-02-26
HUP0102666A2 (hu) 2002-03-28
DE69936449T2 (de) 2008-03-06
ATE366251T1 (de) 2007-07-15
NO20005424L (no) 2000-10-27

Similar Documents

Publication Publication Date Title
DK1123284T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1032566T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1054860T3 (da) Proces for syntesen af 1,3-dioler
DK0708114T3 (da) Fremgangsmåde til fremstilling af alkylerede galactomannaner
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DK1008577T4 (da) Fremgangsmåde til fremstilling af methanol
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK0970939T3 (da) Fremgangsmåde til fremstilling af methanol
DK1075473T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0952137T3 (da) Fremgangsmåde til fremstilling af 2,3,5-trimethylhydroquinondiestere
DK0985733T3 (da) Fremgangsmåde til fremstilling af cyclodextrin
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
DK0970073T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0735043T3 (da) Fremgangsmåde til fremstilling af 2-substitueret 3,3-difluorfuran
DK0800506T3 (da) Opløsningsmiddelfri fremgangsmåde til fremstilling af 2,6-diflourbenzonitril
NO985535L (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
NO20005425L (no) Fremgangsmåte ved fremstilling av 1,3-disubstituert-4- oksocykliske ureaer
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
DK0915076T3 (da) Fremgangsmåde til fremstilling af trans-(R,R)-actinol
DK0981950T3 (da) Fremgangsm,åde til formering af phyllocactus
DK1202949T3 (da) Fremgangsmåde til fremstilling af acylerede 1,3-dicarbonylforbindelser
NO20005743D0 (no) Fremgangsmåte til fremstilling av 4,5-epoksymorfinan-6- oksyglukoronider
DK0884299T3 (da) Fremgangsmåde til fremstilling af 3,3-dimethylsmørsyre
DK0949246T3 (da) Fremgangsmåde til fremstilling af phenoxyphenylsulfonylhalogenider